Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
+14.39%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$20B
AUM Growth
-$1.68B
(-7.8%)
Cap. Flow
-$3.36B
Cap. Flow
% of AUM
-16.84%
Top 10 Holdings %
Top 10 Hldgs %
41.62%
Holding
101
New
13
Increased
21
Reduced
28
Closed
25
Top Buys
| 1 |
UnitedHealth
UNH
|
+$487M |
| 2 |
CSX Corp
CSX
|
+$482M |
| 3 |
Fortinet
FTNT
|
+$348M |
| 4 |
Seagate
STX
|
+$326M |
| 5 |
Amazon
AMZN
|
+$268M |
Top Sells
| 1 |
Dollar General
DG
|
+$521M |
| 2 |
T-Mobile US
TMUS
|
+$446M |
| 3 |
Parker-Hannifin
PH
|
+$430M |
| 4 |
GE Aerospace
GE
|
+$427M |
| 5 |
Meta Platforms (Facebook)
META
|
+$357M |
Sector Composition
| 1 | Healthcare | 37.83% |
| 2 | Financials | 22.09% |
| 3 | Technology | 17.43% |
| 4 | Industrials | 9.52% |
| 5 | Consumer Discretionary | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fortive
FTV
$16.8B
| $250M | 1.25% |
3,890,600
-2,185,600
| -36% | -$140M |
|
|
KRTX
27
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $233M | 1.16% |
1,183,736
+169,620
| +17% | +$33.3M |
|
28
Adaptive Biotechnologies
ADPT
$2.05B
| $229M | 1.15% |
29,993,708
| – | – |
|
29
Brookfield
BN
$103B
| $228M | 1.14% |
7,262,078
-10,992,364
| -60% | -$346M |
|
30
Rogers Communications
RCI
$19.4B
| $205M | 1.03% |
4,375,144
+996,167
| +29% | +$46.6M |
|
31
BridgeBio Pharma
BBIO
$10.1B
| $203M | 1.02% |
26,620,991
| – | – |
|
32
RH
RH
$4.27B
| $200M | 1% |
748,344
+333,615
| +80% | +$89.1M |
|
33
Uber
UBER
$197B
| $196M | 0.98% |
7,939,999
-8,456,108
| -52% | -$209M |
|
34
Molina Healthcare
MOH
$10.2B
| $194M | 0.97% |
588,208
+181,537
| +45% | +$59.9M |
|
35
Li Auto
LI
$24.7B
| $185M | 0.93% |
+9,090,065
| New | +$185M |
|
36
Cadence Design Systems
CDNS
$96.7B
| $182M | 0.91% |
1,134,301
+528,762
| +87% | +$84.9M |
|
37
Amylyx Pharmaceuticals
AMLX
$1.06B
| $171M | 0.86% |
4,634,606
-1,135,930
| -20% | -$42M |
|
38
American International
AIG
$43.6B
| $164M | 0.82% |
+2,590,026
| New | +$164M |
|
|
INBX
39
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $164M | 0.82% |
6,639,199
+1,333,333
| +25% | +$32.9M |
|
40
Valvoline
VVV
$5.15B
| $159M | 0.8% |
4,876,780
-971,059
| -17% | -$31.7M |
|
41
Equitable Holdings
EQH
$16.1B
| $150M | 0.75% |
+5,212,460
| New | +$150M |
|
42
Unum
UNM
$12.8B
| $141M | 0.7% |
3,431,274
-1,643,384
| -32% | -$67.4M |
|
43
Inspire Medical Systems
INSP
$2.45B
| $138M | 0.69% |
549,793
-83,779
| -13% | -$21.1M |
|
44
Advanced Micro Devices
AMD
$253B
| $123M | 0.62% |
+1,905,600
| New | +$123M |
|
45
KE Holdings
BEKE
$23.8B
| $113M | 0.57% |
8,084,334
+4,189,334
| +108% | +$58.5M |
|
46
Charles River Laboratories
CRL
$7.86B
| $112M | 0.56% |
515,168
-143,310
| -22% | -$31.2M |
|
47
Guardant Health
GH
$7.08B
| $112M | 0.56% |
4,107,644
+272,034
| +7% | +$7.4M |
|
48
Clorox
CLX
$15.2B
| $108M | 0.54% |
768,839
+162,184
| +27% | +$22.8M |
|
49
Ginkgo Bioworks
DNA
$618M
| $107M | 0.53% |
1,577,128
-968,725
| -38% | -$65.5M |
|
50
4D Molecular Therapeutics
FDMT
$330M
| $87.5M | 0.44% |
3,937,914
| – | – |
|